Kim's team discovered that, in postmenopausal estrogen deficiency-induced osteoporosis, estrogen signaling mediated by estrogen receptor alpha (ERα) reduces the activity of OXPHOS and CI subunit gene expression in osteoclast progenitors, inhibiting osteoclast differentiation by reducing ATP production. Here, ESR1 is linked to osteoporosis.